Category: Faculty News
Dr. Roth’s lab is on the cutting edge of researching the interaction between brain cell receptors and compounds like LSD and psilocybin. Their findings have the potential to revolutionize the treatment of psychiatric disorders, potentially creating new forms of psychedelics that offer the therapeutic benefits without hallucinations or other side effects.
The $165K award will fund five summer researchers annually. Spearheaded by Program Director, Jonathan Schisler, the program aims to inspire undergraduate students toward careers in cardiovascular research. Becky Sanchez is Program Coordinator, Leon Coleman is an advisory board member, and Edward Bahnson’s and Brian Jensen’s labs are partners with the program.
The Bryan Roth lab got some nice press for their recent Nature paper, revealing structural details of his chemogenetic technology called DREADD – designer receptors exclusively activated by designer drugs – that recognize drug-like but physiologically inert compounds. Postdoc Shicheng Zhang, PhD, led this research published in Nature.